Funding News Edition: January 21, 2021 See more articles in this edition
Now that the new year is underway, you may be filling in your calendar with various events. If you are a researcher who can contribute to the current understanding of pathologies and models available for studying pulmonary injuries, consider adding Developing Medical Countermeasures To Treat the Acute and Chronic Effects of Pulmonary Chemical Injuries (A Trans-Agency Scientific Meeting). There is no fee for attending.
Sponsored by the Chemical Countermeasures Research Program, the meeting takes place from October 13 to 15, 2021, at the National Institute of Environmental Health Sciences (NIEHS/NIH) Rodbell Auditorium in Research Park Triangle, North Carolina.* It will bring together subject matter experts from pulmonary research communities to focus on several topics, including emerging science in pathology, pharmacology, and therapeutics for acute lung injury, acute respiratory distress syndrome, interstitial lung disease, and pulmonary fibrosis.
*The meeting is currently scheduled to be in-person. Organizers will decide in May or June whether to switch it to a virtual gathering.
For planning purposes, take note of the following key dates:
- Registration is currently open; go to the meeting link above, then choose Register Now. Registration closes on September 30, 2021.
- Abstract deadlines:
- February 3, 2021: first submission
- May 5, 2021: second submission
- August 4, 2021: third and final submission
Note: Postdocs as well as early-stage and new investigators who are presenters may receive a travel award (if the meeting remains in-person). Submit abstracts early if you are interested since there is a limited number of travel awards.
For complete meeting details, click on the link above. If you have additional questions, contact one of the listed organizers; NIAID’s is Dr. Dave Yeung.